Skip to content

A study to compare two different doses of a ropivacaine used for nerve block in forearm and hand surgeries using ultrasound guidance

Comparison of the efficacy of 0.375percentage versus 0.5percentage of ropivacaine for ultrasound guided brachial plexus block through costoclavicular space approach in patients undergoing forearm and hand surgeries a randomised double blind non inferiority clinical trial - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/092074
Enrollment
90
Registered
2025-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: Comparison of the efficacy of 0.375% versus 0.5% of ropivacaine for ultrasound guided brachial plexus block through costoclavicular space approach in patients undergoing forearm and han

Sponsors

Karnataka Medical College and Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with upper limb bone fracture ASA 1 and 2

Exclusion criteria

Exclusion criteria: 1. Patients with sensory or motor defecits 2. Allergic to local anaesthetics 3. Prior surgery in the infra clavicular fossa 4. Bleeding tendencies and coagulopathies 5. Infection at the site of injection 6. History of cerebrovascular accidents 7. Patients with emphysema or COPD

Design outcomes

Primary

MeasureTime frame
Sensory and motor blockadeTimepoint: Every five minutes upto thirty minutes from the injection of drug

Secondary

MeasureTime frame
Time taken for reversal of sensory & motor blockade & appearance of painTimepoint: Every one hour till the patient is able to gain the sensations & motor power

Countries

India

Contacts

Public ContactKirana G K

Karnataka Medical College and Research Institute Hubballi

doc_basu@yahoo.co.in6364503729

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026